co-co-2026-00396: STATE BOARD OF PHARMACY RULES AND REGULATIONS

Code of Colorado Regulations eDocket Skip to content  |  About Secretary Griswold  |  Español   Home  Colorado Revised Statutes  Search  Browse  Colorado Register  eDocket  Log in  Contact Us Code of Colorado Regulations eDocket Official Publication of the State Administrative Rules (24-4-103(11) C.R.S.) Details of Tracking Number   2026-00396 CCR details Tracking Number 2026-00396 Type of Filing Permanent Rule Department 700 Department of Regulatory Agencies Agency 719 Division of Professions and Occupations - State Board of Pharmacy CCR Number 3 CCR 719-1 CCR Title STATE BOARD OF PHARMACY RULES AND REGULATIONS Proposed rule Notice Filed with SOS 08/28/2026 Rule ProposedRuleAttach2026-00396.docx Statutory Authority 12-20-204(1), 12-280-107(1), 12-280-114(9) and 24-4-103, C.R.S. Description of Subjects/Issues The Board of Pharmacy will hold a Rulemaking Hearing on Thursday, October 1, 2026, at 9:00 A.M. (MDT), to receive feedback on proposed revisions to multiple rules as follows: 1. Revisions to Rule 2.00.00. The purpose is to align the controlled substance transfer rule with new federal DEA requirements and clarifications. 2. Revisions to Rules 3. The purpose is to implement Colorado House Bill 26-1336. 3. Revisions to Rules 10.00.00 and 14.00.00. The purpose of the proposed revisions is to implement Colorado House Bill 26-1220. 4. Revisions to Rule 11.00.00. The purpose is to align system automation and transfer of controlled substance prescriptions that aligns with new DEA requirements and practice standards. 5. Revisions to Rules 3, 15 and 21. The purpose of these amendments is to refine compounding rules to better align with recent guidance from the FDA and to implement Colorado House Bill 26-1198. 6. Repeal of Rule 28.00.00. The purpose of the repeal is to implement Colorado House Bill 26-1182. 7. Revisions to Rule 19.00.00 – The purpose is to implement Colorado Senate Bill 26-032. 8. Revisions to Rule 23. The purpose is to refine and define the length of time PDMP data is to be retained and/or archived to align better with other states and reduce risk where necessary. 9. Correction to Appendix G. The purpose is to change the word provider to patient as it was originally intended and adopted by the Board. Purpose/Objective of Rule The purpose of this Permanent Rulemaking Hearing was to allow stakeholders a final opportunity to testify before the Board determined on proposed revisions to: 1. Revisions to Rule 2.00.00. The purpose is to align the controlled substance transfer rule with new federal DEA requirements and clarifications. 2. Revisions to Rules 3. The purpose is to implement Colorado House Bill 26-1336. 3. Revisions to Rules 10.00.00 and 14.00.00. The purpose of the proposed revisions is to implement Colorado House Bill 26-1220. 4. Revisions to Rule 11.00.00. The purpose is to align system automation and transfer of controlled substance prescriptions that aligns with new DEA requirements and practice standards. 5. Revisions to Rules 3, 15 and 21. The purpose of these amendments is to refine compounding rules to better align with recent guidance from the FDA and to implement Colorado House Bill 26-1198. 6. Repeal of Rule 28.00.00. The purpose of the repeal is to implement Colorado House Bill 26-1182. 7. Revisions to Rule 19.00.00 – The purpose is to implement Colorado Senate Bill 26-032. 8. Revisions to Rule 23. The purpose is to refine and define the length of time PDMP data is to be retained and/or archived to align better with other states and reduce risk where necessary. 9. Correction to Appendix G. The purpose is to change the word provider to patient as it was originally intended and adopted by the Board. Submitted in response to issues raised by COLS/OLLS? No Is this rule adopted in response to recent legislation? Yes Recent legislation bill number HB26-1336, HB26-1220, HB26-1198, HB26-1182, SB26-032 Hearing Date 10/01/2026 Hearing Time 09:00 AM Hearing Location https://us06web.zoom.us/webinar/register/WN_Io0tODwHRdu5qVP-FODWbA Contact Name Maria Rascon Arana Contact Title Regulatory Coordinator Contact Telephone 303-869-3409 Contact email dora_dpo_rulemaking@state.co.us Adopted rule Adopted Rules AdoptedRules02026-00396.docx Redline Redline2026-00396.docx Adopted Date 10/01/2026 AGO requested date 10/01/2026          Terms & conditions | Accessibility statement | Browser compatibility